Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Runnebaum

Showing results (421-430 of 452) with videos related to

Pageof 46
Sort By:
The New England Journal of Medicine|February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsPhilipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Familial Cancer|September 4, 2014
Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern EuropeNatalia Bogdanova, Alexandr V Togo, Magdalena Ratajska, et al.
Archives of Gynecology and Obstetrics|October 31, 2018
What is the evidence for lymphadenectomy in presumed early ovarian cancer?Barbara Schmalfeldt, Christine Brambs, Alexander Burges, et al.
Cancers|July 20, 2021
Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment SurveillanceHeike Hoyer, Grit Mehlhorn, Cornelia Scheungraber, et al.
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
Gynecologic Oncology|September 9, 2022
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safeW L Van der Kolk, A G J Van der Zee, B M Slomovitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 11, 2012
Polymorphisms in inflammation pathway genes and endometrial cancer riskRyan J Delahanty, Yong-Bing Xiang, Amanda Spurdle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2021
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V IIMaaike H M Oonk, Brian Slomovitz, Peter J W Baldwin, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2016
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial CancerJodie N Painter, Tracy A O'Mara, Louise Marquart, et al.
Pageof 46

Showing results (421-430 of 452) with videos related to

Sort By:
Pageof 46
The New England Journal of Medicine|February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsPhilipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Familial Cancer|September 4, 2014
Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern EuropeNatalia Bogdanova, Alexandr V Togo, Magdalena Ratajska, et al.
Archives of Gynecology and Obstetrics|October 31, 2018
What is the evidence for lymphadenectomy in presumed early ovarian cancer?Barbara Schmalfeldt, Christine Brambs, Alexander Burges, et al.
Cancers|July 20, 2021
Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment SurveillanceHeike Hoyer, Grit Mehlhorn, Cornelia Scheungraber, et al.
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
Gynecologic Oncology|September 9, 2022
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safeW L Van der Kolk, A G J Van der Zee, B M Slomovitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 11, 2012
Polymorphisms in inflammation pathway genes and endometrial cancer riskRyan J Delahanty, Yong-Bing Xiang, Amanda Spurdle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2021
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V IIMaaike H M Oonk, Brian Slomovitz, Peter J W Baldwin, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2016
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial CancerJodie N Painter, Tracy A O'Mara, Louise Marquart, et al.
Pageof 46